Free Trial

Greenbrook TMS (GBNHF) Competitors

$0.11
+0.01 (+10.00%)
(As of 05/31/2024 ET)

GBNHF vs. OTRK, MGRX, BRTX, FMS, DVA, SHC, PGNY, AGL, VMD, and CO

Should you be buying Greenbrook TMS stock or one of its competitors? The main competitors of Greenbrook TMS include Ontrak (OTRK), Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), Fresenius Medical Care (FMS), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), agilon health (AGL), Viemed Healthcare (VMD), and Global Cord Blood (CO). These companies are all part of the "miscellaneous health & allied services, not elsewhere classified" industry.

Greenbrook TMS vs.

Greenbrook TMS (NASDAQ:GBNHF) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.

13.0% of Ontrak shares are held by institutional investors. 21.7% of Greenbrook TMS shares are held by insiders. Comparatively, 1.6% of Ontrak shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Greenbrook TMS has a net margin of -72.39% compared to Ontrak's net margin of -186.35%. Greenbrook TMS's return on equity of 0.00% beat Ontrak's return on equity.

Company Net Margins Return on Equity Return on Assets
Greenbrook TMS-72.39% N/A -73.16%
Ontrak -186.35%-304.29%-107.05%

Ontrak has lower revenue, but higher earnings than Greenbrook TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenbrook TMS$73.79M0.06-$48.91MN/AN/A
Ontrak$12.74M0.95-$27.92M-$4.00-0.06

Greenbrook TMS has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.5, indicating that its stock price is 150% more volatile than the S&P 500.

In the previous week, Ontrak had 2 more articles in the media than Greenbrook TMS. MarketBeat recorded 2 mentions for Ontrak and 0 mentions for Greenbrook TMS. Ontrak's average media sentiment score of 0.44 beat Greenbrook TMS's score of 0.00 indicating that Ontrak is being referred to more favorably in the news media.

Company Overall Sentiment
Greenbrook TMS Neutral
Ontrak Neutral

Ontrak has a consensus price target of $4.00, indicating a potential upside of 1,493.63%. Given Ontrak's higher probable upside, analysts clearly believe Ontrak is more favorable than Greenbrook TMS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenbrook TMS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Ontrak
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Ontrak received 37 more outperform votes than Greenbrook TMS when rated by MarketBeat users.

CompanyUnderperformOutperform
Greenbrook TMSN/AN/A
OntrakOutperform Votes
37
58.73%
Underperform Votes
26
41.27%

Summary

Ontrak beats Greenbrook TMS on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GBNHF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GBNHF vs. The Competition

MetricGreenbrook TMShealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$4.49M$2.28B$5.17B$7.99B
Dividend YieldN/A2.08%2.76%4.00%
P/E RatioN/A14.39108.3314.78
Price / Sales0.066.022,386.0773.53
Price / CashN/A11.2935.4131.55
Price / Book-0.043.245.544.59
Net Income-$48.91M$74.19M$106.07M$213.90M
7 Day PerformanceN/A-4.70%1.14%0.87%
1 Month PerformanceN/A-2.52%0.69%1.82%
1 Year PerformanceN/A-27.63%2.66%5.90%

Greenbrook TMS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OTRK
Ontrak
1.9141 of 5 stars
$0.26
-7.3%
$4.00
+1,468.6%
-90.7%$12.97M$12.74M-0.06102Short Interest ↑
Gap Down
MGRX
Mangoceuticals
0 of 5 stars
$0.44
+7.3%
N/A-64.2%$10.21M$730,000.000.003Short Interest ↓
Gap Down
BRTX
BioRestorative Therapies
3.2856 of 5 stars
$1.29
flat
N/AN/A$8.73M$150,000.00-0.3711Short Interest ↓
Gap Down
FMS
Fresenius Medical Care
3.7922 of 5 stars
$21.33
+0.4%
$24.00
+12.5%
-1.2%$12.52B$19.47B23.971,358Analyst Forecast
Short Interest ↓
Analyst Revision
News Coverage
DVA
DaVita
3.1731 of 5 stars
$143.67
+3.7%
$144.67
+0.7%
+55.3%$12.15B$12.14B16.3370,000Analyst Upgrade
Positive News
SHC
Sotera Health
4.4757 of 5 stars
$11.04
-1.4%
$16.92
+53.2%
-21.2%$3.17B$1.05B58.113,000News Coverage
PGNY
Progyny
4.3466 of 5 stars
$26.67
-1.2%
$43.11
+61.6%
-28.8%$2.57B$1.09B43.72563Positive News
AGL
agilon health
1.4259 of 5 stars
$6.11
+0.3%
$9.25
+51.4%
-67.3%$2.51B$4.32B-8.731,117Analyst Upgrade
VMD
Viemed Healthcare
2.8696 of 5 stars
$7.10
+0.6%
N/A-24.8%$274.08M$183.01M27.311,030Positive News
CO
Global Cord Blood
0 of 5 stars
$1.20
flat
N/A-59.9%$145.86M$1.24B1.881,202Analyst Forecast
Gap Up

Related Companies and Tools

This page (NASDAQ:GBNHF) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners